Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | GS-1423 |
Trade Name | |
Synonyms | AGEN1423|AGEN 1423|AGEN-1423|GS1423|GS 1423 |
Drug Descriptions |
GS-1423 is a bispecific antibody that targets two undisclosed antigens, potentially resulting in increased anti-tumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C167206 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Balstilimab + Gemcitabine + GS-1423 + Nab-paclitaxel | Balstilimab GS-1423 Gemcitabine Nab-paclitaxel | 0 | 1 |
Balstilimab + GS-1423 | Balstilimab GS-1423 | 0 | 1 |
Fluorouracil + GS-1423 + Leucovorin + Oxaliplatin | Fluorouracil GS-1423 Leucovorin Oxaliplatin | 0 | 1 |
GS-1423 | GS-1423 | 0 | 1 |